Source: Pharmaceutical Business Review

Somar: Procaps Group signs agreement to buy Grupo Somar

Grupo Somar is an integrated pharmaceutical company with focus on developing, manufacturing, and marketing branded generic, private label and OTC products aimed at the private market and providing The post Procaps Group signs agreement to buy Grupo Somar appeared first on Pharmaceutical Business review.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Daniel Del Conde's photo - CEO of Somar

CEO

Daniel Del Conde

CEO Approval Rating

- -/100

Read more